Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BRO | MRSH |
|---|---|---|
| Price | $61.92 | $171.45 |
| Change today | ▲ 1.67% | ▲ 1.01% |
| Market cap | $20.72B | $81.82B |
| Return, 3 months | -7.9% | +0.2% |
| Return, year to date | -21.7% | -6.1% |
| Return, 1 year | -32.6% | -13.1% |
| P/E (TTM) | 19.8 | 20.9 |
| P/B | 1.6 | 5.4 |
| P/E percentile vs own 5y | 3rd | 10th |
| Dividend yield | 1.04% | 2.10% |
| Revenue growth (YoY, latest qtr) | +32.4% | +6.2% |
| Net profit growth (YoY) | +23.5% | +4.9% |
| Gross margin | 49.6% | 42.4% |
| Operating margin | 25.3% | 21.6% |
| Net margin | 17.9% | 14.2% |
| Return on equity | 9.9% | 25.7% |
| Analyst target vs. price | +20.3% | +18.9% |
| Analyst buy share | 21% | 33% |
| RSI (14) | 31 | 36 |
| 30-day volatility | 28.7% | 19.2% |
| Max drawdown, 1 year | -42.9% | -23.2% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
